Plunder and Stowaways: Incorporation of Cellular Proteins by Enveloped Viruses
暂无分享,去创建一个
[1] M. Tremblay,et al. Interaction between the Cytoplasmic Domain of ICAM-1 and Pr55Gag Leads to Acquisition of Host ICAM-1 by Human Immunodeficiency Virus Type 1 , 2004, Journal of Virology.
[2] M. Tremblay,et al. Susceptibility of HIV type 1 to the fusion inhibitor T-20 is reduced on insertion of host intercellular adhesion molecule 1 in the virus membrane. , 2004, The Journal of infectious diseases.
[3] V. Pathak,et al. Human Apolipoprotein B mRNA-editing Enzyme-catalytic Polypeptide-like 3G (APOBEC3G) Is Incorporated into HIV-1 Virions through Interactions with Viral and Nonviral RNAs* , 2004, Journal of Biological Chemistry.
[4] W. Sundquist,et al. The Human Endosomal Sorting Complex Required for Transport (ESCRT-I) and Its Role in HIV-1 Budding*♦ , 2004, Journal of Biological Chemistry.
[5] T. Alce,et al. APOBEC3G Is Incorporated into Virus-like Particles by a Direct Interaction with HIV-1 Gag Nucleocapsid Protein* , 2004, Journal of Biological Chemistry.
[6] W. Brown,et al. APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo , 2004, Current Biology.
[7] L. Kleiman,et al. The Interaction between HIV-1 Gag and APOBEC3G* , 2004, Journal of Biological Chemistry.
[8] M. Malim,et al. APOBEC-Mediated Editing of Viral RNA , 2004, Science.
[9] Sunghoon Kim,et al. Cellular Distribution of Lysyl-tRNA Synthetase and Its Interaction with Gag during Human Immunodeficiency Virus Type 1 Assembly , 2004, Journal of Virology.
[10] I. Amit,et al. Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding. , 2004, Genes & development.
[11] C. Claudel-Renard,et al. Human Cytomegalovirus Carries a Cell-Derived Phospholipase A2 Required for Infectivity , 2004, Journal of Virology.
[12] M. Tremblay,et al. Envelope glycoproteins are not required for insertion of host ICAM-1 into human immunodeficiency virus type 1 and ICAM-1-bearing viruses are still infectious despite a suboptimal level of trimeric envelope proteins. , 2004, Virology.
[13] B. Cullen,et al. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins , 2004, The EMBO journal.
[14] Takeshi Kurosu,et al. Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication , 2004, Journal of Virology.
[15] M. Tremblay,et al. HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo. , 2004, Clinical immunology.
[16] H. Garoff,et al. Passive and Active Inclusion of Host Proteins in Human Immunodeficiency Virus Type 1 Gag Particles during Budding at the Plasma Membrane , 2004, Journal of Virology.
[17] M. Prevost,et al. Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding , 2004, Journal of Cell Science.
[18] S. Isaacs,et al. Improved protection conferred by vaccination with a recombinant vaccinia virus that incorporates a foreign antigen into the extracellular enveloped virion. , 2004, Virology.
[19] V. Pathak,et al. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[20] D. Trono,et al. A Single Amino Acid Determinant Governs the Species-specific Sensitivity of APOBEC3G to Vif Action* , 2004, Journal of Biological Chemistry.
[21] A. Gatignol,et al. Identification of Staufen in the Human Immunodeficiency Virus Type 1 Gag Ribonucleoprotein Complex and a Role in Generating Infectious Viral Particles , 2004, Molecular and Cellular Biology.
[22] N. Landau,et al. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] B. Cullen,et al. A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. Booth,et al. Evidence That HIV Budding in Primary Macrophages Occurs through the Exosome Release Pathway* , 2003, Journal of Biological Chemistry.
[25] P. De Camilli,et al. Endophilins interact with Moloney murine leukemia virus Gag and modulate virion production , 2003, Journal of biology.
[26] M. Tremblay,et al. Presence of Host ICAM-1 in Human Immunodeficiency Virus Type 1 Virions Increases Productive Infection of CD4+ T Lymphocytes by Favoring Cytosolic Delivery of Viral Material , 2003, Journal of Virology.
[27] M. Khan,et al. The Human Immunodeficiency Virus Type 1 Vif Protein Reduces Intracellular Expression and Inhibits Packaging of APOBEC3G (CEM15), a Cellular Inhibitor of Virus Infectivity , 2003, Journal of Virology.
[28] Jeremy Luban,et al. Cyclophilin A Interacts with HIV-1 Vpr and Is Required for Its Functional Expression* , 2003, Journal of Biological Chemistry.
[29] W. Sundquist,et al. The Protein Network of HIV Budding , 2003, Cell.
[30] A. Calistri,et al. AIP1/ALIX Is a Binding Partner for HIV-1 p6 and EIAV p9 Functioning in Virus Budding , 2003, Cell.
[31] H. Zentgraf,et al. The Mason-Pfizer Monkey Virus PPPY and PSAP Motifs Both Contribute to Virus Release , 2003, Journal of Virology.
[32] P. Bieniasz,et al. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors , 2003, Nature Medicine.
[33] A. Booth,et al. The Trojan exosome hypothesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[34] N. Moussatché,et al. Redistribution of Cyclophilin A to Viral Factories during Vaccinia Virus Infection and Its Incorporation into Mature Particles , 2003, Journal of Virology.
[35] Stanislaus S. Wong,et al. The pH dependence of HIV-1 capsid assembly and its interaction with cyclophilin A. , 2003, Biophysical chemistry.
[36] L. Arthur,et al. Cholesterol Depletion of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus with β-Cyclodextrin Inactivates and Permeabilizes the Virions: Evidence for Virion-Associated Lipid Rafts , 2003, Journal of Virology.
[37] M. Bergeron,et al. Virion-bound ICAM-1 and activated LFA-1: a combination of factors conferring resistance to neutralization by sera from human immunodeficiency virus type 1-infected individuals independently of the disease status and phase. , 2003, Clinical immunology.
[38] R. König,et al. Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif , 2003, Cell.
[39] S. Scarlata,et al. Role of HIV-1 Gag domains in viral assembly. , 2003, Biochimica et biophysica acta.
[40] Gersende Caron,et al. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts , 2003, Nature.
[41] A. Banerjee,et al. Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype. , 2003, The Journal of general virology.
[42] M. Malim,et al. DNA Deamination Mediates Innate Immunity to Retroviral Infection , 2003, Cell.
[43] D. Gerlier,et al. Virus Entry, Assembly, Budding, and Membrane Rafts , 2003, Microbiology and Molecular Biology Reviews.
[44] G. Quérat,et al. Differential incorporation of uracil DNA glycosylase UNG2 into HIV-1, HIV-2, and SIV(MAC) viral particles. , 2003, Virology.
[45] Ziying Han,et al. Overlapping Motifs (PTAP and PPEY) within the Ebola Virus VP40 Protein Function Independently as Late Budding Domains: Involvement of Host Proteins TSG101 and VPS-4 , 2003, Journal of Virology.
[46] W. Sundquist,et al. Mechanisms of enveloped RNA virus budding. , 2002, Trends in cell biology.
[47] D. Ott. Potential roles of cellular proteins in HIV‐1 , 2002, Reviews in medical virology.
[48] Geoffrey L. Smith,et al. An investigation of incorporation of cellular antigens into vaccinia virus particles. , 2002, The Journal of general virology.
[49] S. Misumi,et al. Three Isoforms of Cyclophilin A Associated with Human Immunodeficiency Virus Type 1 Were Found by Proteomics by Using Two-Dimensional Gel Electrophoresis and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry , 2002, Journal of Virology.
[50] L. M. Mansky,et al. Roles of uracil-DNA glycosylase and dUTPase in virus replication. , 2002, The Journal of general virology.
[51] E. Freed,et al. Viral Late Domains , 2002, Journal of Virology.
[52] J. Luban,et al. Specific Incorporation of Heat Shock Protein 70 Family Members into Primate Lentiviral Virions , 2002, Journal of Virology.
[53] P. Gallay,et al. Cyclophilin A Plays Distinct Roles in Human Immunodeficiency Virus Type 1 Entry and Postentry Events, as Revealed by Spinoculation , 2002, Journal of Virology.
[54] D. A. Bosco,et al. Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[55] H. Kräusslich,et al. Differential dependence of the infectivity of HIV-1 group O isolates on the cellular protein cyclophilin A. , 2002, Virology.
[56] P. Gallay,et al. trans-Complementation Rescue of Cyclophilin A-Deficient Viruses Reveals that the Requirement for Cyclophilin A in Human Immunodeficiency Virus Type 1 Replication Is Independent of Its Isomerase Activity , 2002, Journal of Virology.
[57] M. Tremblay,et al. Presence of Host ICAM-1 in Laboratory and Clinical Strains of Human Immunodeficiency Virus Type 1 Increases Virus Infectivity and CD4+-T-Cell Depletion in Human Lymphoid Tissue, a Major Site of Replication In Vivo , 2002, Journal of Virology.
[58] E. Freed,et al. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[59] M. Tremblay,et al. A novel virus capture assay reveals a differential acquisition of host HLA-DR by clinical isolates of human immunodeficiency virus type 1 expanded in primary human cells depending on the nature of producing cells and the donor source. , 2001, The Journal of general virology.
[60] Wesley I. Sundquist,et al. Tsg101 and the Vacuolar Protein Sorting Pathway Are Essential for HIV-1 Budding , 2001, Cell.
[61] B. Seed,et al. Lipid Rafts and Pseudotyping , 2001, Journal of Virology.
[62] L. Verplank,et al. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[63] M. Bukrinsky,et al. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[64] P. Woodman,et al. TSG101/Mammalian VPS23 and Mammalian VPS28 Interact Directly and Are Recruited to VPS4-induced Endosomes* , 2001, The Journal of Biological Chemistry.
[65] W. Song,et al. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases. , 2001, International immunopharmacology.
[66] U. Schubert,et al. Ubiquitination of HIV-1 and MuLV Gag. , 2000, Virology.
[67] S. Goff,et al. The Carboxy-Terminal Fragment of Nucleolin Interacts with the Nucleocapsid Domain of Retroviral Gag Proteins and Inhibits Virion Assembly , 2000, Journal of Virology.
[68] L. M. Mansky,et al. The Interaction of Vpr with Uracil DNA Glycosylase Modulates the Human Immunodeficiency Virus Type 1 In Vivo Mutation Rate , 2000, Journal of Virology.
[69] M. Luo,et al. The Double-Stranded RNA-Binding Protein Staufen Is Incorporated in Human Immunodeficiency Virus Type 1: Evidence for a Role in Genomic RNA Encapsidation , 2000, Journal of Virology.
[70] D. Ott,et al. Efficient Incorporation of HLA Class II onto Human Immunodeficiency Virus Type 1 Requires Envelope Glycoprotein Packaging , 2000, Journal of Virology.
[71] Dzung H. Nguyen,et al. Evidence for Budding of Human Immunodeficiency Virus Type 1 Selectively from Glycolipid-Enriched Membrane Lipid Rafts , 2000, Journal of Virology.
[72] M. Bergeron,et al. Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization. , 2000, Virology.
[73] Xiao Zhen Zhou,et al. Actin-binding cellular proteins inside human immunodeficiency virus type 1. , 2000, Virology.
[74] D. Gerlier,et al. Measles Virus Structural Components Are Enriched into Lipid Raft Microdomains: a Potential Cellular Location for Virus Assembly , 2000, Journal of Virology.
[75] P. Gallay,et al. Host cyclophilin A mediates HIV‐1 attachment to target cells via heparans , 1999, The EMBO journal.
[76] B. Spire,et al. Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules. , 1999, AIDS.
[77] K. Wallengren,et al. Localization of actin in Moloney murine leukemia virus by immunoelectron microscopy. , 1999, Virology.
[78] U. Schubert,et al. Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid. , 1999, Virology.
[79] H. Kräusslich,et al. In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A. , 1999, Virology.
[80] F. Rey,et al. DNA Repair Enzyme Uracil DNA Glycosylase Is Specifically Incorporated into Human Immunodeficiency Virus Type 1 Viral Particles through a Vpr-Independent Mechanism , 1999, Journal of Virology.
[81] D. Streblow,et al. Gag protein from human immunodeficiency virus type 1 assembles in the absence of cyclophilin A. , 1998, Virology.
[82] J. Paquette,et al. Level of ICAM-1 Surface Expression on Virus Producer Cells Influences both the Amount of Virion-Bound Host ICAM-1 and Human Immunodeficiency Virus Type 1 Infectivity , 1998, Journal of Virology.
[83] S. Zolla-Pazner,et al. Role of cellular adhesion molecules in HIV type 1 infection and their impact on virus neutralization. , 1998, AIDS research and human retroviruses.
[84] J. Luban,et al. Human Immunodeficiency Virus Type 1 Replication Is Modulated by Host Cyclophilin A Expression Levels , 1998, Journal of Virology.
[85] M. Tremblay,et al. The acquisition of host-encoded proteins by nascent HIV-1. , 1998, Immunology today.
[86] Robert B Sim,et al. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[87] L. Arthur,et al. Ubiquitin Is Covalently Attached to the p6GagProteins of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus and to the p12Gag Protein of Moloney Murine Leukemia Virus , 1998, Journal of Virology.
[88] Michael M. Endrich,et al. The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood. , 1998, European journal of biochemistry.
[89] M. J. Tremblay,et al. T Cells Expressing Activated LFA-1 Are More Susceptible to Infection with Human Immunodeficiency Virus Type 1 Particles Bearing Host-Encoded ICAM-1 , 1998, Journal of Virology.
[90] O. Schwartz,et al. Cytosolic Gag p24 as an Index of Productive Entry of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[91] M. Bukrinsky,et al. Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[92] D. Ott. Cellular proteins in HIV virions , 1997, Reviews in medical virology.
[93] J. Atkinson,et al. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. , 1997, The Journal of general virology.
[94] M. Tremblay,et al. The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells. , 1997, Blood.
[95] F. Jensen,et al. Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles , 1997, Journal of virology.
[96] J. Sodroski,et al. Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization , 1997, Journal of virology.
[97] M. Tremblay,et al. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity , 1997, Journal of virology.
[98] J. Luban,et al. The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein , 1997, Journal of virology.
[99] M. Tremblay,et al. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity , 1997, Journal of virology.
[100] L. Arthur,et al. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions , 1996, Journal of virology.
[101] J. Luban,et al. Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses , 1996, Journal of virology.
[102] M. Tremblay,et al. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. , 1996, Virology.
[103] L. Picard,et al. Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A , 1996, Journal of virology.
[104] P. Cresswell,et al. HLA class II on HIV particles is functional in superantigen presentation to human T cells: implications for HIV pathogenesis. , 1995, AIDS research and human retroviruses.
[105] N. Lurain,et al. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). , 1995, Journal of immunology.
[106] L. Young,et al. Epstein-Barr virus infection of CR2-transfected epithelial cells reveals the presence of MHC class II on the virion. , 1995, Virology.
[107] S. Zolla-Pazner,et al. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1 , 1995, The Journal of experimental medicine.
[108] A. Kurosky,et al. Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts , 1995, Journal of virology.
[109] J. Sodroski,et al. Functional association of cyclophilin A with HIV-1 virions , 1994, Nature.
[110] J. Luban,et al. Specific incorporation of cyclophilin A into HIV-1 virions , 1994, Nature.
[111] R. Luftig,et al. Viral interactions with the host-cell cytoskeleton: the role of retroviral proteases. , 1994, Trends in microbiology.
[112] S. Bartz,et al. An Hsp60 related protein is associated with purified HIV and SIV , 1994, Journal of medical primatology.
[113] L. Arthur,et al. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. , 1992, Science.
[114] A. Meyerhans,et al. Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes , 1991, Journal of virology.
[115] V. Vogt,et al. Ubiquitin in avian leukosis virus particles. , 1990, Virology.
[116] R. Stein,et al. Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes. , 1990, Biochemistry.
[117] P. Griffiths,et al. Cytomegalovirus strain AD169 binds beta 2 microglobulin in vitro after release from cells. , 1987, The Journal of general virology.
[118] E. Freed,et al. Retrovirus budding. , 2004, Virus research.
[119] H. Kräusslich,et al. The Human Endosomal Complex Required for Transport I (ESCRT-I) and its Role in HIV-1 Budding* , 2004 .
[120] M. Esteban,et al. Recombinant proteins produced by vaccinia virus vectors can be incorporated within the virion (IMV form) into different compartments , 2001, Archives of Virology.
[121] P. Gallay,et al. Human immunodeficiency virus type 1 hijacks host cyclophilin A for its attachment to target cells , 2000, Immunologic research.
[122] C. Seeger,et al. Hepadnavirus assembly and reverse transcription require a multi‐component chaperone complex which is incorporated into nucleocapsids , 1997, The EMBO journal.
[123] S. Odend'hal. Vesicular Stomatitis Virus (New Jersey Serotype) , 1983 .